RXO:NYSERXO, Inc. Analysis
Data as of 2026-08-15 - not real-time
$23.52
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind RXO, Inc. is neutral at $23.52, with no clear ordering between short and long averages. The last 30 days have lost 15.2%. RSI sits at 48.7, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $19.40 up to resistance at $29.90.
Valuation screens as fair: a P/E of 38.5 sits above the sector average of 30.9. Analyst price targets sit 4.0% above the current price. Revenue is growing at 25.0% on a -1.7% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 66.0%, a beta of 1.95 and a maximum drawdown of 43.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Valuation screens as fair: a P/E of 38.5 sits above the sector average of 30.9. Analyst price targets sit 4.0% above the current price. Revenue is growing at 25.0% on a -1.7% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 66.0%, a beta of 1.95 and a maximum drawdown of 43.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
CHARLOTTE, N.C., August 06, 2026--RXO NYSE: RXO today reported its second-quarter financial results and third-quarter...CHARLOTTE, N.C., July 13, 2026--RXO NYSE: RXO will issue its second-quarter financial results before the opening of the...RXO stock has surged year to date, yet valuation checks are split, with the Discounted Cash Flow DCF intrinsic value...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 18.37
- MACD momentum is positive
- 30-day price change of -15.2%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 38.5 versus sector average of 30.9
- Trading above the 200-day average of 18.37
- 30-day volatility of 66.0%
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 38.5 versus sector average of 30.9
- Negative profit margin of -1.7%
- Negative return on equity of -6.8%
Key Metrics & Analysis
Financial Health
Revenue Growth25.00%
Profit Margin-1.72%
P/E Ratio38.5
ROE-6.79%
ROA-0.26%
Debt/Equity48.34
P/B Ratio2.6
Op. Cash Flow$-17000000
Free Cash Flow$5.8M
Industry P/E30.9
Technical Analysis
TrendNeutral
RSI48.7
Support$19.40
Resistance$29.90
MA 20$23.81
MA 50$25.79
MA 200$18.37
MACDBullish
VolumeStable
Fear & Greed Index95.98
Valuation
Target Price$24.47
Upside/Downside4.05%
GradeFair
TypeGrowth
Risk Assessment
Beta1.95
Volatility65.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.